[Tree] Jefferies raises Tourmaline Bio stock target on strong momentum

Version 0.07 (2024-03-21 04:25:53.893000)

updates: Jefferies raises price target for Tourmaline Bio stock

  • ➔
Version 0.06 (2024-03-20 03:27:26.094000)

updates: Inclusion of information about Axsome Therapeutics' coverage initiation and positive trial outlook

  • ➔
  • ➔
Version 0.05 (2024-03-19 21:25:42.738000)

updates: Added information about Aquestive Therapeutics' stock offering

  • ➔
Version 0.04 (2024-03-19 20:25:31.524000)

updates: Arcturus Therapeutics maintains Buy rating and $79 target on successful Phase III study results for Covid vaccine

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.03 (2024-02-14 14:46:37.484000)

updates: Includes price target increase for Viking Therapeutics

  • ➔
  • ➔
  • ➔
Version 0.02 (2024-02-06 12:16:07.703000)

updates: Public offering by Kyverna Therapeutics

  • ➔
  • ➔
Version 0.01 (2023-11-28 03:02:48.030000)

updates: Announcement of Tharimmune's public offering to advance therapeutic candidates

  • ➔
Version 0.0 (2023-11-21 07:50:04.967000)

updates:

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔